How Interferon-Alpha Treats Rare Blood Cancers: Study Reveals Mechanism
Published in Nature Genetics, recent research from Weill Cornell Medicine details how the biologic drug interferon-alpha treats myeloproliferative neoplasms, such as essential thrombocythemia. By forcing mutant blood stem cells into ... Read More